II. Mechanism
- Alkylating Agents are not Cell Cycle specific
- Exert cytotoxic effects via transfer of unstable alkyl group
- DNA alkylation (key to cellular lethality, esp. DNA cross linking)
- Chemically react with other cellular constituents (e.g. Proteins)
- Replicating cells and rapidly growing cells are most susceptible to agents (related to adverse effects)
- Blood cell precursors
- Hair cells
- Gastrointestinal cells
- Cancer resistance mechanisms
- Decreased Chemotherapeutic Drug uptake
- Repair of DNA damage
III. Medications
- Nitrogen Mustard Antineoplastic Compounds (Bis -chloroethyl- amines)
- Bendamustine
- Chlorambucil
- Cyclophosphamide (prodrug, activated in liver)
- Ifosfamide (prodrug, activated in liver)
- Mechlorethamine
- Melphalan
- Nitrosourea Compounds
- Carmustine (BCNU)
- Lomustine (CCNU)
- Semustine (Methyl-CCNU)
- Streptozocin
- Aziridines (Ethyleneimine)
- Thiotepa
- Triethylenemelamine
- Mesylate (Alkylsulfonate)
- Triazene Antineoplastic
- Procarbazine
- Dacarbazine
- Temozolamide
- Platinum Analogs
- Other drugs causing alkylation
- Hexamethylmelamine
- Trabectedin
IV. References
- Olson (2020) Clinical Pharmacology, Medmaster, Miami, Fl, p. 126
- Amjad (2023) Cancer Chemotherapy, StatPearls, Treasure Island, Fl, accessed 2/1/3/2024